<DOC>
	<DOCNO>NCT01824225</DOCNO>
	<brief_summary>Evaluate treatment result every two month versus need ( PRN ) 3 initial monthly intravitreal aflibercept Japanese age related macular degeneration .</brief_summary>
	<brief_title>Study PRN Every 2months Intravitreal Aflibercept Age Related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Clinical diagnosis agerelated macular degeneration Any treatment intravitreal Aflibercept agerelated macular degeneration . Visual acuity 0.1 decimal visual acuity</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>aflibercept</keyword>
	<keyword>intravitreal injection</keyword>
</DOC>